Chiara Salio

Prof. Chiara Salio

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2008 in Progress in Neurobiology
Verified
Journal Article
Closed access
AMAdalberto Merighi
Adalberto Merighi
CSChiara Salio
Chiara Salio
AGA Ghirri
A Ghirri
LLL Lossi
L Lossi
FFFrancesco Ferrini
Francesco Ferrini
RBRita Bardoni
Rita Bardoni

1 March 2009 in Current Neuropharmacology
Verified
Journal Article
Open access
PDF file
FFFrancesco Ferrini
Francesco Ferrini
CSChiara Salio
Chiara Salio
LLL. Lossi
L. Lossi
AMAdalberto Merighi
Adalberto Merighi
Ghrelin, an orexigenic peptide synthesized by endocrine cells of the gastric mucosa, is released in the bloodstream in response to a negative energetic status. Since discovery, the hypothalamus was identified as the main source of ghrelin in the CNS, and effects of the peptide have been mainly observed in this area of the brain. In recent years, an increasing number of studies have reported ghrelin synthesis and effects in specific populations of neurons also outside the hypothalamus. Thus, ghrelin activity has been described in midbrain, hindbrain, hippocampus, and spinal cord. The spectrum of functions and biological effects produced by the peptide on central neurons is remarkably wide and complex. It ranges from modulation of membrane excitability, to control of neurotransmitter release, neuronal gene expression, and neuronal survival and proliferation. There is not at present a general consensus concerning the source of ghrelin acting on central neurons. Whereas it is widely accepted that the hypothalamus represents the most important endogenous source of the hormone in CNS, the existence of extra-hypothalamic ghrelin-synthesizing neurons is still controversial. In addition, circulating ghrelin can theoretically be another natural ligand for central ghrelin receptors. This paper gives an overview on the distribution of ghrelin and its receptor across the CNS and critically analyses the data available so far as regarding the effects of ghrelin on central neurotransmission.

18 July 2006 in Cell and tissue research
Verified
Journal Article
Closed access
PDF file
CSChiara Salio
Chiara Salio
LLLaura Lossi
Laura Lossi
FFFrancesco Ferrini
Francesco Ferrini
AMAdalberto Merighi
Adalberto Merighi

1 December 2001 in NeuroReport
Verified
Journal Article
Closed access
CSChiara Salio
Chiara Salio
JFJacqueline Fischer
Jacqueline Fischer
MFMaria Fosca Franzoni
Maria Fosca Franzoni
KMKen Mackie
Ken Mackie
TKTakeshi Kaneko
Takeshi Kaneko
MCMarie Conrath
Marie Conrath
Cannabinoids and opioids interact in the control of nociception at the spinal level. Likely, several mechanisms are involved, with one of them being co-localization of cannabinoid and opioid receptors. In order to validate this hypothesis, a double labeling study of CB1 cannabinoid receptors and mu-opioid receptors in the dorsal horn of the rat spinal cord was performed. A strong co-localization of CB1 and mu-opioid receptors was observed in lamina II interneurons at the ultrastructural level. The physiological consequences of the co-localization are discussed.

1 August 2009 in Progress in Neurobiology
Verified
Journal Article
Closed access
LLLaura Lossi
Laura Lossi
SASilvia Alasia
Silvia Alasia
CSChiara Salio
Chiara Salio
AMAdalberto Merighi
Adalberto Merighi

1 April 2002 in Neuroscience
Verified
Journal Article
Closed access
CSChiara Salio
Chiara Salio
JFJ Fischer
J Fischer
MFM.F Franzoni
M.F Franzoni
MCM Conrath
M Conrath